CLC bio achieves massive growth in 2009 and closes year with 7-figure deal
Press release - January 07, 2010Download this press release as a PDF-file.
| Download PDF (pdf-file) |
Aarhus, Denmark and Boston, USA -- January 7, 2010 -- Today CLC bio is happy to announce that their financial year 2009 was closed with a 7-figure US Dollar deal involving a multinational corporation working extensively with high-throughput sequencing data analysis on multiple levels.

The agreement also means that CLC bio managed a year over year increase in sales of more than 130% during 2009 compared to 2008, whereas 2007 to 2008 resulted in an increase of 108%.

CLC bio has started 2010 with opening new offices in Stockholm, Sweden and in Rotterdam, Netherlands. CLC bio now has offices in 9 countries around the globe to better serve customers in the pharmaceutical industry, agricultural biotechnology, human biotechnology, as well as government and academic research institutes.
About CLC bio
http://www.clcbio.com/aboutContact CLC bio
Thomas Knudsen, CEO
PPhone: +45 70 22 55 09
E-mail: info@clcbio.com


















